Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models

Brain Research

Volumn 1347, Issue , 2010, Pages 179-185

  Nicholson, Rachel M ^a,b,c   Kusne, Yael ^a,b,c   Nowak, Lee A ^a,c   Laferla, Frank M ^d   Reiman, Eric M ^c,e,f,g   Valla, Jon ^a,c  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c ARIZONA ALZHEIMER S CONSORTIUM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BANNER ALZHEIMER S INSTITUTE   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Animal models; Energy metabolism; Functional brain imaging; Glucose uptake; Transgenic mice

Indexed keywords

FLUORODEOXYGLUCOSE; AMYLOID PRECURSOR PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CEREBELLUM CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DENSITOMETRY; GENE MUTATION; GLUCOSE TRANSPORT; GRAY MATTER; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; AGE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN CORTEX; C57BL MOUSE; DIAGNOSTIC USE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING;

ANIMALIA; MUS; MUS MUSCULUS;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESENILIN-1; TAU PROTEINS;

EID: 77955981090     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.084     Document Type: Article

References (32)

1. Aggleton, J. P., Hunt, P. R., Nagle, S., Neave, N., 1996. The effects of selective lesions within the anterior thalamic nuclei on spatial memory in the rat. Behav. Brain Res. 81, 189-198.
2. Alexander, G. E., Chen, K., Petrini, P., Rapoport, S. I., Reiman, E. M., 2002. Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 159, 738-745.
3. Anandatheerthavarada, H. K., Biswas, G., Robin, M. A., Avadhani, N. G., 2003. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41-54.
4. Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., Diamond, D. M., 2001. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891, 42-53.
5. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., Laferla, F. M., 2005. Intraneuronal Aß causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
6. Dodart, J.-C., Mathis, C., Bales, K. R., Paul, S. M., Ungerer, A., 1999. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717Fß-amyloid precursor protein. Neurosci. Lett. 277, 49-52.
7. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., Younkin, S., 1996. Increased amyloid-beta42 (43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
8. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Sorlano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., Zhao, J., 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
9. Gonzalez-Lima, F., Garrosa, M., 1991. Quantitative histochemistry of cytochrome oxidase in rat brain. Neurosci. Lett. 123, 251-253.
10. Gonzalez-Lima, F., Berndt, J. D., Valla, J. E., Games, D., Reiman, E. M., 2001. Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport 12, 2375-2379.
11. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., Sanders, S., Zehr, C., O'Campo, K., Hardy, J., Prada, C. M., Eckman, C., Younkin, S., Hsiao, K., Duff, K., 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97-100.
12. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., Cole, G., 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
13. Kuntner, C., Kesner, A. L., Bauer, M., Kremslehner, R., Wanek, T., Mandler, M., Karch, R., Stanek, J., Wolf, T., Muller, M., Langer, O., 2009. Limitations of small animal PET imaging with [18F] FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease. Mol. Imaging Biol. 11, 236-240.
14. Mielke, R., Herholz, K., Grond, M., Kessler, J., Heiss, W. D., 1994. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5, 36-41.
15. Minoshima, S., Foster, N. L., Kuhl, D. E., 1994. Posterior cingulate cortex in Alzheimer's disease. Lancet 344, 895.
16. Minoshima, S., Frey, K. A., Koeppe, R. A., Foster, N. L., Kuhl, D. E., 1995. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 36, 1238-1248.
17. Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., Kuhl, D. E., 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42, 85-94.
18. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., LaFerla, F. M., 2003a. Triple-transgenic mouse model of Alzheimer's disease with plaques and tangles: Intracellular Aß and synaptic dysfunction. Neuron 39, 409-421.
19. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B. P., LaFerla, F. M., 2003b. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 24, 1063-1070.
20. Paxinos, G., Franklin, K. B. J., 2001. The mouse brain in stereotaxic coordinates. Academic Press, San Diego.
21. Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., Osborne, D., 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Eng. J. Med. 334, 752-758.
22. Reiman, E. M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N. L., Berndt, J. D., Games, D., 2000. Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 11, 987-991.
23. Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., Frost, J., 2001. Declining brain activity in cognitively normal apolipoprotein E varepsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98, 3334-3339.
24. Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., Hardy, J., 2004. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 101, 284-289.
25. Valla, J., Berndt, J. D., Gonzalez-Lima, F., 2001. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J. Neurosci. 21, 4923-4930.
26. Valla, J., Chen, K., Berndt, J. D., Gonzalez-Lima, F., Cherry, S. R., Games, D., Reiman, E. M., 2002. Effects of image resolution on autoradiographic measurements of posterior cingulate activity in PDAPP mice: Implications for functional brain imaging studies of transgenic mouse models of Alzheimer's disease. Neuroimage 16, 1-6.
27. Valla, J., Schneider, L. E., Reiman, E. M., 2006a. Nonprogressive transgene-related callosal and hippocampal changes in PDAPP mice. NeuroReport 17, 829-832.
28. Valla, J., Schneider, L., Reiman, E. M., 2006b. Age-and transgene-related changes in regional cerebral metabolism in PSAPP mice. Brain Res. 1116, 194-200.
29. Valla, J., Schneider, L. E., Small, A. M., Gonzalez-Lima, F., 2007. Quantitative cytochrome oxidase histochemistry: Applications in human Alzheimer's disease and animal models. J. Histotechnology 30, 235-247.
30. Valla, J., Gonzalez-Lima, F., Reiman, E. M., 2008. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice. Int. J. Dev. Neurosci. 26, 253-258.
31. Vann, S. D., Aggleton, J. P., 2003. Evidence of a spatial encoding deficit in rats with lesions of the mammillary bodies or mammillothalamic tract. J. Neurosci. 23, 3506-3514.
32. Vann, S. D., Brown, M. W., Aggleton, J. P., 2000. Fos expression in the rostral thalamic nuclei and associated cortical regions in response to different spatial memory tests. Neuroscience 101, 983-991.